pharma news today obesity drugs glp-1 A $60 billion industry just found its next growth lever. π With the expiry of a key patent on March 20, 2026, Indian majors are launching generic weight-loss and diabetes How Supply and Demand for
Description
Because of a shortage of brand-name drugs, it was legal
Certain groups of people should not use Semaglutide GLP-1 or should use it with caution under healthcare professional supervision
2007, Pujadas et al
Most of the small molecules now in development bind in this same general region and exploit the Trp33 anchor
Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama VA, Helmerhorst FM, Stijnen T, et al
Two weeks after initiation of the antibiotics, we administered a single subcutaneous injection of liraglutide or saline to the mice
